Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-banding of carboplatin vs individualised dosing (AUC comparison)
2006-001094-15Phase 4Completed
- Sponsor
- Oxford University Hospitals
- Start
- Apr 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carboplatin in Non-hematologic malignancy (2 arms), sponsored by Oxford University Hospitals. Started Apr 2006; status: completed.
02
Drugs
carboplatin
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on 2006-001094-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001094-15.